Influenza Market Research Reports & Industry Analysis
Influenza Industry Research & Market Reports
-
Influenza Diagnostic Tests Market - By Test Type (Traditional Diagnostic Test {RIDT, DFAT, Viral Culture, Serological Assay}, Molecular Diagnostic Assay {RT-PCR, LAMP, NASBAT, SAMBA}), End-use & Forecast, 2023 - 2032
... estimated to witness 6.3% CAGR between 2023 and 2032, owing to the recurrent global outbreaks of influenza that highlight the critical need for accurate and rapid diagnostic solutions. As per WHO October 2023 report, there ... Read More
-
U.S. Influenza Diagnostics Market Size, Share & Trends Analysis Report By Test Type (RIDT, RT-PCR, Cell Culture, Others), By End-use (Hospitals, POCT, Laboratories), And Segment Forecasts, 2023 - 2030
... Trends The U.S. influenza diagnostics market size is expected to reach USD 282.9 million by the year 2030 growing at a CAGR of 5.9% according to a new report by Grand View Research, Inc. Key ... Read More
-
Influenza Diagnostic Global Market Report 2024
... Amplification Tests (INAAT); Loop Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays3) By End User: Hospitals And Clinical Laboratories; Diagnostic Reference Laboratories; Academic/Research Institutes Covering: F. ... Read More
-
Influenza Diagnostics Market Size, Share & Trends Analysis Report By Test Type (RIDT, RT-PCR, Cell Culture), By End Use (Hospitals, Laboratories, POCT), By Region, And Segment Forecasts, 2023 - 2030
... Trends The global influenza diagnostics market size is expected to reach USD 1.46 billion by 2030, registering a CAGR of 3.6% from 2023 to 2030, according to a new report by Grand View Research, Inc. ... Read More
-
Influenza Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 9.8 Billion by 2028, exhibiting a CAGR of 7.93% during 2022-2028. The increasing awareness about the importance of vaccination, rising prevalence of influenza, and favorable government initiatives promoting vaccination programs are some of ... Read More
-
Seasonal Influenza Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
... Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Seasonal Influenza Clinical trials scenario. This report provides top line data relating to the clinical trials on Seasonal Influenza. Report includes an ... Read More
-
Respiratory Syncytial Virus (RSV) Infections Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
... Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Respiratory Syncytial Virus (RSV) Infections Clinical trials scenario. This report provides top line data relating to ... Read More
-
Vaccines Market by Technology (Recombinant, Toxoid, Conjugate, RNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Influenza, DTP, HPV, MMR, COVID-19), Route of Administration (IM, SC, Oral), End user (Pediatric, Adult) & Region - Global Forecast to 2028
... The global vaccines market size is projected to reach USD 93.8 billion by 2028 from USD 77.6 billion in 2023, at a CAGR of 3.9% during the forecast period. Factors such as high incidence of ... Read More
-
Influenza Vaccines Market Report 2023-2033
... dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. The global prevalence of influenza is on the rise. The ... Read More
-
Global Respiratory Disease Vaccine Market Size study & Forecast, by Type (Viral Vaccine, Bacterial Vaccine, Combination Vaccine) by Age Group (Pediatric, Adult), by Infection (COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Pneumonia, Others), by Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, Others) and Regional Analysis, 2023-2030
... (Hospital & Retail Pharmacies, Government Suppliers, Others) and Regional Analysis, 2023-2030 Global Respiratory Disease Vaccine Market is valued approximately USD 92.23 billion in 2022 and is anticipated to grow with a healthy growth rate of ... Read More
-
Viral Vector & Plasmid DNA Manufacturing Market by Cell Line (In-vitro, In-Vivo), Type (Adeno-Associated Virus, Adenovirus, Lentivirus), Transfection, Indication, Workflow, Application, End User - Global Forecast 2023-2030
... is projected to reach USD 7.32 billion by 2030 from USD 1.20 billion in 2022, at a CAGR of 25.30% during the forecast period. Market Segmentation & Coverage: This research report analyzes various sub-markets, forecasts ... Read More
-
Seasonal Influenza Vaccines Epidemiology Analysis and Forecast to 2032
... and B cause human disease of public health concern (WHO, 2023). Influenza transmission occurs when people with the flu cough, sneeze, or talk, thereby disseminating droplets. These droplets can land in the mouths or noses ... Read More
-
Infectious Disease Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product & Service (Assays, Kits, & Reagents, Instruments, Services & Software), By Technology (Molecular Diagnostics, Immunoassay, Microbiology, Others), By Disease (Hepatitis, Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Hospital-Acquired Infections (HAIs), Others), By End User (Hospital and Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Others), By Region and Competition
... an anticipated Compound Annual Growth Rate (CAGR) of 4.89% through 2028. Losartan is a medication primarily prescribed for the treatment of high blood pressure (hypertension) and specific heart conditions. It falls under the category of ... Read More
-
Global Influenza Vaccine Market: Analysis by Valency (Quadrivalent & Trivalent), By Vaccine Type (Inactivated And Live Attenuated), By Technology (Egg-based & Cell-based), By Age Group (Adult & Pediatric), By Route Of Administration (Injection & Nasal Spray), By Distribution Channel (Hospitals And Pharmacy, Government And Institutions And Others), By Region Size And Trends With Impact Of COVID-19 And Forecast Up To 2028
... Spray), By Distribution Channel (Hospitals And Pharmacy, Government And Institutions And Others), By Region Size And Trends With Impact Of COVID-19 And Forecast Up To 2028 The influenza vaccine, often referred to as the flu ... Read More
-
MENA Biologics & Biosimilars Market, By Product Type (Influenza Vaccines, Factor VIII ( Xyntha, Octanate, Kovaltry, Advate, Koate, Adynovate, Kogenate, Hemlibra, Elocta, Recombinate, Feiba, Immunate, Alphanate, Novoeight), Erythropoietin (Epoetin Alfa (Procrit, Epogen), Darbepoietin Alfa (Aranesp), Epoetin Alfa-epbx (Retacrit)), Aflibercept (EYLEA), and Ziv-Aflibercept (ZALTRAP))), By Therapeutic Application (Hemophilia, Age-related Macular Degeneration, Kidney Diseases, Influenza, and Others), By Geography (Gulf and Egypt)
... Epoetin Alfa-epbx (Retacrit)), Aflibercept (EYLEA), and Ziv-Aflibercept (ZALTRAP))), By Therapeutic Application (Hemophilia, Age-related Macular Degeneration, Kidney Diseases, Influenza, and Others), By Geography (Gulf and Egypt) MENA Biologics & Biosimilars Market, By Product Type (Influenza Vaccines, ... Read More
-
Global Respiratory Syncytial Virus Diagnostic Market 2023-2030
... Antibody Method, Immunoassays and Others), and by End-Users (Hospitals, Clinics, and Laboratories), Forecast Period (2023-2030) The global respiratory syncytial virus diagnostic market is anticipated to grow at a significant CAGR of 6.5% during the forecast ... Read More
-
Global Epstein-Barr Virus Diagnosis and Treatment Market 2023-2030
... Other Drugs), Forecast Period (2023-2030) The global Epstein - Barr virus diagnosis and treatment market is anticipated to grow at a considerable CAGR of 5.1% during the forecast period (2023-2030). The considerable prevalence of the ... Read More
-
Glycomic Therapeutics Global Market Report 2023 Including: 1) By Class: Isolated; Synthetic 2) By Structures: Glycoproteins; Targeting Sialic Acid; Proteoglycans; Targeting Glycosaminoglycans; Glycosylphosphatidylinositol (GPI)-Anchored Proteins And Heparin Based Glycans; Targeting Glycosphingolipids 3) By Mode Of Action: Inhibits Neuraminidase; Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate; Erythropoietin And Enzyme Replacement Therapy (ERT); Tissue Plasminogen Activator; Inhibits Glucosylceramide Synthase; Interleukin 1, 2 And 3; Beta And Gamma Interferons 4) By Indications: Thrombosis And Chemoprophylaxis; Anemia; Anti-Adhesive And Anti-Inflammatory; Cataracts; Gaucher’s Disease; Mps-1 And IV; Cancer; Alzheimer’s Disease; Influenza Type A And B Covering: F Hoffmann-La Roche Ltd.; Bayer AG; Sanofi SA; Thermo Fisher Scientific Inc.; GlaxoSmithKline plc
... Neuraminidase; Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate; Erythropoietin And Enzyme Replacement Therapy (ERT); Tissue Plasminogen Activator; Inhibits Glucosylceramide Synthase; Interleukin 1, 2 And 3; Beta And Gamma Interferons4) ... Read More
-
Influenza Vaccines Global Market Report 2023 Including: 1) By Vaccine Type: Inactivated; Live Attenuated 2) By Valency: Quadrivalent; Trivalent 3) By Route Of Administration: Injection; Nasal Spray 4) By Age Group: Pediatric; Adult 5) By Distribution Channel: Hospitals And Pharmacies; Government And Institutional Supply Covering: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Novartis AG; Sanofi-Aventis LLC.
... Pharmacies; Government And Institutional SupplyCovering: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Novartis AG; Sanofi-Aventis LLC. Influenza Vaccines Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior ... Read More
-
Global Respiratory Syncytial Virus (RSV) Vaccine And Antibody Pipeline Market: Analysis By End User (Adult and Maternal & Pediatric), By Type (Vaccine & Antibody), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2030
... up to 2030 RSV, or respiratory syncytial virus, is a common respiratory virus that causes mild, cold-like symptoms in both the upper and lower respiratory tracts. RSV can be harmful, especially in infants and the ... Read More
-
Global Influenza Vaccines Market, Persons Vaccinated, Key Company Analysis, Emerging Players Profile, Promising Influenza Vaccines in Clinical Development, Size, Share, Trends, Major Deals and Recent Developments - Forecast to 2030
... is projected to reach US$ 10.9 Billion by 2030. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The Centers for Disease Control and Prevention (CDC) recommends routine seasonal influenza vaccination ... Read More
-
Global Influenza Drugs Market Size study & Forecast, by Drug Type (Ribavirin, Oseltamivir, Relenza (Zanamivir), Peramivir, Influenza Vaccines), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Channel) and Regional Analysis, 2023-2030
... is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Influenza is a common viral infection that, ... Read More
-
Global Foot-and-Mouth Disease Virus Fluorescent Quantitative PCR Detection Kit Market Growth 2023-2029
... US$ million in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Foot-and-Mouth Disease Virus Fluorescent Quantitative PCR Detection Kit is forecast to a readjusted size ... Read More
-
Global Monkeypox Virus Real-Time PCR Kit Market Growth 2023-2029
... demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Monkeypox Virus Real-Time PCR Kit is forecast to a readjusted size of US$ million by 2029 with a CAGR of ... Read More
-
Global Influenza Vaccines Market - 2023-2030
... influenza vaccines market is expected to exhibit a CAGR of 6.9% during the forecast period (2023-2030). Influenza (flu) vaccinations (flu shots) are vaccines that protect against the four influenza viruses that are expected to be ... Read More
Research Assistance
